Skip to content
Subscriber Only

Drug Company Soars More Than 1000% In Just Two Days

Aquinox Pharmaceuticals Inc. soared more than fivefold after an analyst said the drug development company had a better-than-expected shot at getting its treatment for bladder pain and eczema to the market.

The stock climbed to an intraday record high of $55.75 before giving back some gains. It was trading at $29.45 at 12:55 p.m. in New York -- still more than double Friday’s closing price and leaps beyond Thursday’s close of $1.79. Aquinox was the biggest gainer Monday on the Nasdaq Composite Index.